Unifying the Treatment Community

National Methadone Conference AMTA 2001

Sunday, October 7th


Pre-conference Meeting

This special pre-conference meeting is divided into two sessions – a morning and afternoon session. These sessions have been developed by the Advocacy Coalition: National Alliance of Methadone Advocates (NAMA), Advocates for Recovery through Medicine (ARM), Advocates For the Integration of Recovery and Methadone (AFIRM), Virginia Alliance of Methadone Advocates (VAMA), and Addiction Treatment Watchdog, and are designed to take the combined knowledge and experience of the advocacy community and present concepts that will assist in the understanding of medication assisted treatments like methadone and LAAM, as well as the new regulations (42 CRF Part 8) and accreditation, from both the patient’s and the staff’s perspective. Audiences for these sessions include patients, counselors, medical and administrative personnel, advocates and all others involved in the field of opioid agonist treatment.

8:30 A.M. to 12 Noon Session: Accreditation, Networking and Skill Building

Nuts and Bolts of Regulations/Accreditation
Presenter: C. Todd Rosendale, CSAT/OPAT

Group Discussion on Advocacy
Moderator: Joycelyn Woods, NAMA

Networking & How Best to Utilize Time and Skills at a Conference
Presenters: Joycelyn Woods & Jo Sotheran, NAMA

1 P.M. to 5 P.M. Session: The Vision Of The Future

The Graying of Methadone Maintnenace Treatment
Presenter: C. Todd Rosendale, CSAT/OPAT

Making Accreditation Work For You: a How-To for Patients and Programs
Presenter: Joycelyn Woods, NAMA

Warm and Fuzzy With the Community
Presenter: Fred Christie, AFIRM

How to Start an Advocacy Group
Presenter: James DePasquale, NAMA

Methadone Works; Medical Efficacy From the Patient’s Perspective
Presenter: Sean P. Murphy

Pictures

Howard is Ready

Howard is Ready!

Howard Lotsof, Acting Membership Director and member of NAMA’s Board prepares for the preconference day.

Jo Presents

Jo Makes a Point

Jo Presents.

Jo Sotheran, Treasurer and member of NAMA’s board talks about the importance of planning at a conference.

Jo Makes a Point and shows the advocates how to use a conference program to set goals for a conference.

Donna Schoen helps James DePasquale.

Donna Schoen (LIJ Patient Committee) helps James DePasquale, former Membership Director talk about starting an advocacy group.

Operations and Oversight!

Operations and Oversight

Jo Sotheran talks methadone politics and patient rights with Joycelyn S. Woods, NAMA’s President

Sponsored by the Center for Substance Abuse Treatment


Return to AMTA 2001 Index

Similar Posts

  • In Memory of Ira Sobel

    Admin 03/26/2022

    New York City Many of you may not know who Ira was but to those who knew him from his writings and articles that appeared in many of our affiliates newsletters he was special. In many ways he was the typical patient who had been “hood winked” by the misinformation and negative barrage about methadone….

  • NAMA Affiliates Pages

    Admin 10/23/2022

    Affiliates Package The first 2 parts of the Affiliates Package are in Ebook format. This means that your computer sees the file as an application and it will have an “exe” file extension. If you click on the file like it is an application – the Ebook with the documents will open. You can then…

  • Office Based Opioid Treatment

    Admin 04/17/2023

    Treatment INDEX   OBOT PUBLICATIONS- Federal Code, Manuals, Teaching Packets, and other OBOT information.   BASIC INFORMATION FOR PHYSICIANS   NAMA’s Comments to the Federation of State Medical Boards   Physicians’ Guide: Opioid Agonist Medical Maintenance Treatment   Using Buprenorphine for Office Based Opioid Treatment (pdf file)   Manual For Methadone Medical Management (pdf file)

  • How Methadone Works by Joycelyn Woods

    Admin 06/24/2021

    National Alliance of Methadone Advocates The Pharmacology of Methadone Ignorance about methadone abounds. Professionals working in the field receive very little or no training at all about the very medication that they will be administering. Rarely is addiction viewed as a disease and under the domain of the medical profession. Even the medical profession does…

  • Category: Press Release

    Admin 07/14/2022

    Herman Joseph, PhD 1931 – 2019 May 28, 2019 May 6, 2019 Dr. Joseph was one of the important influences on addiction and criminal justice during the latter 20th and early 21st century.  For more than 50 years he has worked as a social research scientist in the interrelated fields of addiction, treatment, criminal justice,…

  • Page 4098 Federal Register

    Admin 08/28/2021

     Vol. 66, No. 11 / Wednesday, January 17, 2001 / Rules and Regulations (i)                 Unsupervised or take-home use.   To limit the potential for diversion of opioid agonist treatment medications to the illicit market, opioid agonist treatment medications dispensed to patients for unsupervised use shall be subject to the following requirements.   (1)   Any patient…